{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:03:30Z","timestamp":1788905010621,"version":"build-2803163510"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Breast cancer remains a leading cause of cancer-related mortality among women globally. While advances in early diagnosis and systemic therapies have improved survival, they have also increased the likelihood of brain metastases over time, particularly in low-resource settings where limited diagnostic and treatment capacity exacerbates the burden of late-stage disease. The study aimed to determine the prevalence and describe the clinicopathological characteristics of breast cancer patients diagnosed with brain metastasis in a limited-resource healthcare setting. This research was a single-institution-based quantitative cross-sectional study. Socio-demographic, clinical and pathological data were extracted from patients\u2019 medical records as well as the hospital-based cancer registry. Data were analyzed using STATA software (version 16). Descriptive and logistic regression analyses were performed. The study involved 144 adult female metastatic breast cancer patients with a mean age of 48.7 years (SD 11.3). The prevalence of brain metastasis was 17.5%. Only 4.9% presented with de novo brain metastasis, p\u2009&lt;\u20090.001. Bone metastases were present in 31.9% whereas 26.4% and 12.5% had concurrent lung and liver metastasis respectively. In all, 38.9% had grade III tumors. Also, 50.6% were categorized as recursion partition analysis (RPA) class II whereas 49.3% had a performance status of ECOG 2. A considerable majority (86.8%) were treated with palliative intent whereas 13.2% received best supportive care only. In total, 86.8% underwent radiotherapy whereas 81.3% received systemic treatments, with chemotherapy being the most frequently utilized modality (73.5%). Most patients (88%) were treated with 2-dimensional radiotherapy whereas 3.2% received hippocampal-sparing intensity-modulated radiotherapy. The high prevalence of brain metastasis among breast cancer patients with distant metastases reflects the challenges associated with late-stage breast cancer presentation and limited access to advanced diagnostic and therapeutic interventions in limited-resource healthcare settings.<\/jats:p>","DOI":"10.1371\/journal.pone.0329308","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T17:30:36Z","timestamp":1754674236000},"page":"e0329308","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and clinicopathological characteristics of breast cancer patients with brain metastases in Ghana: A single-center cross-sectional study"],"prefix":"10.1371","volume":"20","author":[{"given":"Joseph","family":"Daniels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3485-5368","authenticated-orcid":true,"given":"Kofi Adesi","family":"Kyei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Walubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Yaw","family":"Nyantakyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwina Ayaaba","family":"Ayabilah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith Naa Odey","family":"Tackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"3","key":"pone.0329308.ref001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"F Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"14","key":"pone.0329308.ref002","doi-asserted-by":"crossref","first-page":"12682","DOI":"10.18632\/oncotarget.3707","article-title":"Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells","volume":"6","author":"RM Burnett","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"pone.0329308.ref003","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jcp.2003.013623","article-title":"Pathobiology of brain metastases","volume":"58","author":"N Nathoo","year":"2005","journal-title":"J Clin Pathol"},{"issue":"17","key":"pone.0329308.ref004","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1200\/JCO.2004.01.175","article-title":"CNS metastases in breast cancer","volume":"22","author":"NU Lin","year":"2004","journal-title":"J Clin Oncol"},{"issue":"6","key":"pone.0329308.ref005","doi-asserted-by":"crossref","first-page":"650","DOI":"10.18632\/oncotarget.27453","article-title":"Risk factors for breast cancer brain metastases: a systematic review","volume":"11","author":"L Koniali","year":"2020","journal-title":"Oncotarget"},{"issue":"1","key":"pone.0329308.ref006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jjco\/hyn124","article-title":"Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan: results of a nationwide survey by the task force of the Japanese Breast Cancer Society","volume":"39","author":"K Matsumoto","year":"2009","journal-title":"Jpn J Clin Oncol"},{"issue":"12","key":"pone.0329308.ref007","first-page":"2535","article-title":"Occurrence of brain metastases in metastatic breast cancer","volume":"98","author":"KD Miller","year":"2003","journal-title":"Cancer"},{"issue":"12","key":"pone.0329308.ref008","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/jjco\/hyu156","article-title":"Brain metastases in breast cancer","volume":"44","author":"N Niikura","year":"2014","journal-title":"Jpn J Clin Oncol"},{"issue":"19","key":"pone.0329308.ref009","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1002\/cncr.27434","article-title":"Incidence of brain metastases as a first site of recurrence among women with triple receptor-negative breast cancer","volume":"118","author":"S Dawood","year":"2012","journal-title":"Cancer"},{"issue":"6","key":"pone.0329308.ref010","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/annonc\/mdt036","article-title":"Incidence and risk of central nervous system metastases as site of first recurrence in patients with HER2-positive breast cancer treated with adjuvant trastuzumab","volume":"24","author":"EM Olson","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"pone.0329308.ref011","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO Guideline","volume":"40","author":"MA Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"issue":"6","key":"pone.0329308.ref012","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-0043-1776782","article-title":"Management of brain metastases: a review of novel therapies","volume":"43","author":"S Bellur","year":"2023","journal-title":"Semin Neurol"},{"issue":"7","key":"pone.0329308.ref013","first-page":"764","article-title":"Brain metastases in HER2-positive breast cancer: the evolving role of systemic therapies","volume":"22","author":"G Tomasello","year":"2017","journal-title":"The Oncologist"},{"issue":"3","key":"pone.0329308.ref014","first-page":"97","article-title":"Management of brain metastases in breast cancer patients: Current treatment paradigms","volume":"21","author":"RK Murthy","year":"2020","journal-title":"Lancet Oncol"},{"issue":"5","key":"pone.0329308.ref015","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/j.ijrobp.2011.02.027","article-title":"Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases","volume":"82","author":"PW Sperduto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"pone.0329308.ref016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbcan.2016.12.001","article-title":"Brain metastasis: Unique challenges and open opportunities","volume":"1867","author":"FJ Lowery","year":"2017","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"pone.0329308.ref017","doi-asserted-by":"crossref","first-page":"806344","DOI":"10.3389\/fneur.2022.806344","article-title":"Quality of life and role of palliative and supportive care for patients with brain metastases and caregivers: a review","volume":"13","author":"A Wu","year":"2022","journal-title":"Front Neurol"},{"key":"pone.0329308.ref018","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2023.7111","article-title":"Revisiting the association of ECOG performance status with clinical outcomes in diverse patients with cancer","volume":"22","author":"D Kumar","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"pone.0329308.ref019","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","article-title":"Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials","volume":"37","author":"L Gaspar","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"pone.0329308.ref020","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4614-1353-0","volume-title":"Regression methods in biostatistics: Linear, logistic, survival, and repeated measures models","author":"E Vittinghoff","year":"2012","edition":"2"},{"key":"pone.0329308.ref021","volume-title":"Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. 64th WMA General Assembly","author":"WM Association","year":"2013"},{"issue":"2","key":"pone.0329308.ref022","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"M Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pone.0329308.ref023","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13036-023-00352-w","article-title":"Breast cancer brain metastasis: from etiology to state-of-the-art modeling","volume":"17","author":"MK Farahani","year":"2023","journal-title":"J Biol Eng"},{"key":"pone.0329308.ref024","article-title":"Delayed diagnosis and late-stage breast cancer in Africa: insights from a Nigerian cohort","author":"CA Adebamowo","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"pone.0329308.ref025","article-title":"Challenges to effective cancer control in Africa: data gaps, resource constraints, and limited knowledge","author":"PE Goss","year":"2014","journal-title":"Lancet Oncol"},{"key":"pone.0329308.ref026","doi-asserted-by":"crossref","first-page":"4429","DOI":"10.1158\/1078-0432.CCR-06-3045","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"R Dent","year":"2007","journal-title":"Clin Cancer Res"},{"key":"pone.0329308.ref027","article-title":"Global disparities in the treatment of brain metastases from breast cancer","author":"D Nicholas","year":"2019","journal-title":"J Glob Oncol"},{"key":"pone.0329308.ref028","article-title":"Epidemiology and survival of breast cancer patients with brain metastases in the United States","author":"G Witman","year":"2022","journal-title":"J Clin Oncol"},{"key":"pone.0329308.ref029","article-title":"Breast cancer brain metastases in Nigeria: Clinicopathological features and survival","author":"AO Adisa","year":"2020","journal-title":"J Oncol"},{"key":"pone.0329308.ref030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40164-015-0028-8","article-title":"Breast cancer brain metastases: the last frontier","volume":"4","author":"JP Leone","year":"2015","journal-title":"Exp Hematol Oncol"},{"key":"pone.0329308.ref031","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2147\/JMDH.S301337","article-title":"Factors associated with delay in breast cancer presentation at the only oncology center in North East Ethiopia: A cross-sectional study","volume":"14","author":"AM Hassen","year":"2021","journal-title":"J Multidiscip Healthc"},{"key":"pone.0329308.ref032","article-title":"Socioeconomic determinants of cancer outcomes in Ghana: An analysis of national cancer registry data","author":"FA Mensah","year":"2022","journal-title":"Glob Health Action"},{"key":"pone.0329308.ref033","article-title":"Employment status and cancer outcomes in the United States: a nationwide study","author":"BD Smith","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"pone.0329308.ref034","article-title":"Racial disparities in breast cancer outcomes: the role of genetic and environmental factors","author":"DR Parkinson","year":"2020","journal-title":"Cancer Med"},{"key":"pone.0329308.ref035","article-title":"Breast cancer genetics in African populations: A comprehensive review","author":"OI Olopade","year":"2019","journal-title":"Cancer Res"},{"issue":"6","key":"pone.0329308.ref036","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/neuonc\/noaa285","article-title":"The incidence of brain metastases among patients with metastatic breast cancer: a systematic review and meta-analysis","volume":"23","author":"M Kuksis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"6","key":"pone.0329308.ref037","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1158\/1078-0432.CCR-06-2478","article-title":"Brain metastases: the HER2 paradigm","volume":"13","author":"NU Lin","year":"2007","journal-title":"Clin Cancer Res"},{"key":"pone.0329308.ref038","article-title":"Palliative care in low-income countries: The role of surgical oncology","author":"TP Kingham","year":"2015","journal-title":"Lancet Glob Health"},{"key":"pone.0329308.ref039","article-title":"Immunotherapy in brain metastases from breast cancer: current perspectives","author":"F Elkabir","year":"2021","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"pone.0329308.ref040","first-page":"1","article-title":"Clinical implications of brain metastases in breast cancer patients","volume":"118","author":"NU Lin","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"pone.0329308.ref041","article-title":"Radiotherapy for brain metastases: an updated systematic review and meta-analysis","author":"MN Tsao","year":"2012","journal-title":"J Clin Oncol"},{"issue":"10","key":"pone.0329308.ref042","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1200\/JCO.19.02767","article-title":"Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: Phase III trial NRG oncology CC001","volume":"38","author":"PD Brown","year":"2020","journal-title":"J Clin Oncol"},{"issue":"1","key":"pone.0329308.ref043","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1186\/s12885-020-07011-z","article-title":"Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG)","volume":"20","author":"A-L Grosu","year":"2020","journal-title":"BMC Cancer"},{"key":"pone.0329308.ref044","article-title":"Radiotherapy techniques in breast cancer patients with brain metastasis: Challenges in low-resource settings","author":"MA Zubair","year":"2020","journal-title":"Radiat Oncol J"},{"issue":"5","key":"pone.0329308.ref045","article-title":"Relationship between HER2 status and prognosis in women with brain metastases from breast cancer","volume":"82","author":"Z Xu","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"pone.0329308.ref046","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2018-000440","article-title":"Risk factors for the development of brain metastases in patients with HER2-positive breast cancer","volume":"3","author":"C Maurer","year":"2018","journal-title":"ESMO Open"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0329308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T17:30:42Z","timestamp":1754674242000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0329308"}},"subtitle":[],"editor":[{"given":"Drokow Emmanuel","family":"Kwateng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0329308","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]}}}